1. Home
  2. PACS vs LNTH Comparison

PACS vs LNTH Comparison

Compare PACS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PACS Group Inc.

PACS

PACS Group Inc.

HOLD

Current Price

$35.25

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$84.69

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACS
LNTH
Founded
2013
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.3B
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
PACS
LNTH
Price
$35.25
$84.69
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$45.50
$87.00
AVG Volume (30 Days)
734.1K
538.0K
Earning Date
02-26-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
221.05
N/A
EPS
1.22
3.41
Revenue
$5,288,932,000.00
$343,374,000.00
Revenue This Year
$10.19
N/A
Revenue Next Year
$8.58
$14.19
P/E Ratio
$28.93
$24.60
Revenue Growth
29.32
3.62
52 Week Low
$7.50
$47.27
52 Week High
$43.08
$108.86

Technical Indicators

Market Signals
Indicator
PACS
LNTH
Relative Strength Index (RSI) 54.56 65.03
Support Level $33.18 $72.35
Resistance Level $36.11 N/A
Average True Range (ATR) 1.52 2.15
MACD 0.25 0.12
Stochastic Oscillator 58.14 90.08

Price Performance

Historical Comparison
PACS
LNTH

About PACS PACS Group Inc.

PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: